Page 10 - Zai Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SHANGHAI & CAMBRIDGE, Mass., April 02, 2024--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that two poster presentations highlighting ongoing global clinical studies in its oncology pipeline will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2024 taking place April 5-10, 2024, in San Diego, California.

Serendipity Arts Festival (SAF) has announced the curatorial line-up for the ninth edition of the festival which is scheduled in Panaji, Goa from December 15 to December 22.The curators are tasked with the mandate of investigating the ...

(RTTNews) - Bristol Myers Squibb (BMY) said Phase 3 KRYSTAL-12 study, evaluating KRAZATI or adagrasib as a monotherapy in patients with pretreated...

OOOLAB, a top Vietnamese educational technology company, is providing businesses with unique learning and training software.

Zai Lab Ltd.'s (ZLAB) partner Novocure Ltd. (NVCR) announced on Wednesday that its phase 3 clinical trial in Tumor Treating Fields therapy for patients with 1-10 brain metastases from non-small cell lung cancer or NSCLC, has met its primary endpoint by demonstrating significant improvement in intracranial progression.